Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Code:
NCT05581030
Conditions
Acute Lymphoblastic Leukemia
Eligibility Criteria
Sex: All
Age: 18 - 50
Healthy Volunteers: Not accepted
Interventions
Hyper CVAD Protocol (Standard of Care Multi-Agent Chemotherapy)
Calaspargase Pegol
Rituximab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by H. Lee Moffitt Cancer Center and Research Institute on 2025-02-06.